HIGHLIGHTS
- who: Lisha Sun from the Department of Oncology, Innovative Cancer Drug Research and Translation Medicine Lab, Shengjing Hospital of China Medical University have published the research: Targeting SOST using a small-molecule compound retards breast cancer bone metastasis, in the Journal: (JOURNAL) of 27/Oct/2022
- how: It is unclear whether can be used as a therapeutic target for metastases of and whether compounds that target in cells can inhibit Methods expression in 442 tissues was characterized by immunohistochemistry and statistically analyzed for the association with metastases. metastatic SCP2 cells were induced for silencing or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.